自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

  • <tfoot id="icskm"></tfoot>
  • <code id="icskm"><xmp id="icskm"></xmp></code>
  • <li id="icskm"><input id="icskm"></input></li>
    <code id="icskm"></code>
  • <cite id="icskm"><center id="icskm"></center></cite><button id="icskm"><bdo id="icskm"></bdo></button><code id="icskm"></code>
  • <cite id="icskm"><pre id="icskm"></pre></cite>
    <button id="icskm"></button>
  • <rt id="icskm"><pre id="icskm"></pre></rt>
    <cite id="icskm"></cite>
    <li id="icskm"></li>
    <button id="icskm"><input id="icskm"></input></button>
  • 159-2642-3062 027-65317797
    服務(wù)熱線(工作日:9:00-17:30)

    瀏覽量: 250

    • 產(chǎn)品名稱: Research Grade Figitumumab ( 芬妥木單抗 )
    • 產(chǎn)品貨號: CSD00192
    • 貨期: 現(xiàn)貨
    • 價格與訂購: 2480
    • 數(shù)量:
      庫存: 100
    • 規(guī)格: 100μg
    • 產(chǎn)品信息
    • 如何訂購
      貨號(Catalog No.)
      CSD00192
      通用名INN
      Figitumumab
      純度(Purity)
      >95%
      濃度( Concentration)
      1mg/ml
      Formulation
      PBS buffer PH7.5
      Source
      CHO cells
      內(nèi)毒素(Endotoxin level)
      Please contact with the lab for this information.
      產(chǎn)品描述(Description)
      Figitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.
      別名(Alternative names)
      CP-751871
      靶點;物種(Specificity target name;species)
      IGF1R/CD221[Homo sapiens]
      活性研究(體外/體內(nèi)研究)(Activity in vitro)
      BMS-754807 effectively inhibits the growth of a broad range of human tumor cell lines with IC50 values of ranging from 5 to 365 nM. BMS-754807 also inhibits the proliferation of human rhabdomyosarcoma tumor cells Rh41 and human colon carcinoma Geo with IC50s of 7 and 5 nM, respectively. BMS-754807 shows inhibitory activity in the proliferation of Rh41 cells with IC50 of 5 nM. BMS-754807 inhibits the phosphorylation of IGF-1R (IC50=13 nM) and the downstream targets Akt (IC50=22 nM) and MAPK (IC50=13 nM) in the IGF-Sal cell line with IC50 consistent with the antiproliferative IC50 (7 nM) in this cell line. BMS-754807 shows a median EC50 value of 0.62 μM against the PPTP cell lines. The median EC50 for the four Ewing sarcoma cell lines is less than that for the remaining PPTP cell lines (0.19 μM vs. 0.78 μM, P=0.0470). BMS-754807 (0.25 and 0.5 μM) reduces the activated IGF-IR/IR (pIGF-IR/IR), causes a concurrent decrease in phosphorylated AKT in both lung cancer cell lines. BMS-754807 (0.5 μM) also reduces wound closure of lung cancer cells and reduces the ERK phosphorylation. BMS-754807 reduces cell viability in both A549 and NCI-H358 cells, with IC50 of 1.08 μM and 76 μM, respectively.
      種類(Species)
      Homo sapiens
      受體鑒定(Receptor identification)
      IgG2-kappa
      CAS
      943453-46-1
      存儲條件(Storage)
      Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
      Store at +4°C short term (1-2 weeks).
      Store at -20 °C 12 months.
      Store at -80°C long term.
      Note
      For research use only .
    阳朔县| 龙口市| 荆州市| 留坝县| 富裕县| 汶上县| 霍州市| 威远县| 武清区| 阿克苏市| 威宁| 定日县| 汝城县| 石狮市| 温泉县| 徐水县| 富顺县| 乌兰察布市| 西乡县| 五河县| 防城港市| 山阴县| 瓮安县| 芦山县| 蒙城县| 镇康县| 成都市| 雷州市| 丰都县| 辽阳县| 六安市| 石柱| 扬中市| 洞口县| 加查县| 伊春市| 苏州市| 开封市| 南昌市| 太湖县| 盐山县|